(URGN) Urogen Pharma complete technical analysis [charts+indicators] | Buy/Sell Urogen Pharma | (URGN) share price targets
Complete technical analysis of Urogen Pharma (URGN) by charts plus indicators, forecast predictions and share price targets for Urogen Pharma (URGN)
Urogen Pharma trades in USA in Health Care sector.
10 day averaged volume of Urogen Pharma is 469520
Date | Daily Closing Price | Open | High | Low | Volume |
11 Mon Nov 2024 | 12.79 | 12.28 | 12.81 | 12.08 | 0.924 times |
08 Fri Nov 2024 | 12.12 | 12.05 | 12.30 | 11.93 | 0.453 times |
07 Thu Nov 2024 | 12.10 | 12.24 | 12.53 | 12.01 | 0.647 times |
06 Wed Nov 2024 | 12.24 | 13.25 | 13.37 | 11.76 | 1.464 times |
05 Tue Nov 2024 | 12.21 | 11.93 | 12.30 | 11.66 | 1.138 times |
04 Mon Nov 2024 | 11.93 | 12.15 | 12.33 | 11.84 | 0.735 times |
01 Fri Nov 2024 | 12.20 | 12.33 | 12.66 | 12.07 | 1.285 times |
31 Thu Oct 2024 | 12.26 | 13.02 | 13.13 | 12.24 | 0.841 times |
30 Wed Oct 2024 | 13.02 | 12.22 | 13.33 | 12.16 | 2.01 times |
29 Tue Oct 2024 | 12.25 | 12.10 | 12.45 | 12.03 | 0.902 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 12.6, but if it comes below 12.6, then a intra day sell could be more profitable.
If you take a sell trade below 12.6, then use 12.6 as stoploss and 12.35 as target. However if you take a buy trade in stock , then use 12.6 as stoploss and 13 as target.
Share price targets for Urogen Pharma (URGN)
Target Type | Value |
Downside Target | 11.30 |
Downside Target | 11.66 |
Downside Target | 12.60 |
Upside Target | 13.33 |
Upside Target | 13.37 |
Upside Target | 13.64 |
Upside Target | 13.69 |
Upside Target | 14.57 |
Upside Target | 14.89 |
Upside Target | 16.50 |
Upside Target | 18.15 |
Intraday share price targets for Urogen Pharma (URGN)
Target Type | Value |
Downside Intraday Target | 12.31 |
Downside Intraday Target | 11.83 |
Upside Intraday Target | 13.04 |
Upside Intraday Target | 13.29 |
Downside Intraday Target | 12.56 |
Weekly technical analysis of Urogen Pharma (URGN)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Mon Nov 2024 | 12.79 | 12.28 | 12.81 | 12.08 | 0.208 times |
08 Fri Nov 2024 | 12.12 | 12.15 | 13.37 | 11.66 | 0.798 times |
01 Fri Nov 2024 | 12.20 | 12.26 | 13.33 | 12.03 | 1.185 times |
25 Fri Oct 2024 | 12.10 | 12.79 | 12.82 | 11.89 | 0.437 times |
18 Fri Oct 2024 | 12.73 | 12.94 | 13.64 | 11.84 | 0.863 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Urogen Pharma (URGN)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Mon Nov 2024 | 12.79 | 12.33 | 13.37 | 11.66 | 0.187 times |
31 Thu Oct 2024 | 12.26 | 12.63 | 13.64 | 11.30 | 1.613 times |
30 Mon Sep 2024 | 12.70 | 13.83 | 14.57 | 12.60 | 0.896 times |
30 Fri Aug 2024 | 13.91 | 16.50 | 16.50 | 13.69 | 1.17 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Urogen Pharma (URGN)
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.4 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.4 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.